Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5
摘要:
Optimization of a screening hit from uHTS led to the discovery of TGR5 agonist 32, which was shown to have activity in a rodent model for diabetes. (C) 2010 Elsevier Ltd. All rights reserved.
[EN] HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE<br/>[FR] MODULATEURS HÉTÉROCYCLIQUES DE TGR5 POUR LE TRAITEMENT DES MALADIES
申请人:KALYPSYS INC
公开号:WO2008097976A1
公开(公告)日:2008-08-14
[EN] Disclosed herein are compounds useful as modulators of TGR5 and methods for the treatment or prevention of metabolic, cardiovascular, and inflammatory diseases. [FR] L'invention concerne des composés utiles comme modulateurs de TGR5 et procédés pour le traitement ou la prévention des maladies métaboliques, cardiovasculaires et inflammatoires.